Maternal autoantibodies linked to autism subtype, recurrence risk
Contemporary Pediatrics
Specific combinations of maternal autoantibodies are linked to a non-genetic subtype of autism, known as MARA, which is associated with a high recurrence risk in younger siblings. Findings from MARAbio suggest these autoantibodies may cross the placenta and affect fetal brain development, offering potential for more individualized recurrence risk counseling. The MAR-Autism Test, a maternal blood test, shows high specificity and positive predictive value in detecting these autoantibodies, though it is not validated for use during pregnancy.
Read at Contemporary Pediatrics
All articles from 17 November 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.
Get this news by email
Daily or as a weekly roundup in your inbox. You confirm your address first; every email has an unsubscribe link. For another topic or language, use the subscribe page.